JVA vs MED
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
JVA
MED
Investment Advisor Scores
MED
AI Analyst Insights
Detailed Metrics Comparison
| Metric | JVA | MED | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 13.3869 | 12.4844 | MED |
| PEG Ratio | 0.893 | 0.972 | JVA |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -9.3% | -27.6% | JVA |
| Earnings Growth | -59.2% | -87.2% | JVA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 26.4/100 | 45.5/100 | MED |
| Profit Margin | 4.9% | -8.1% | JVA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | MED |
Relative Price Performance (Last 90 Days)
Current Technical Phase
JVA
MarkupPrice above SMA50, rising 50-day trend (10.4% over 20 days), RSI 58
MED
NeutralMixed signals - no dominant trend phase, RSI 47
Fundamentals Snapshot
| Metric | JVA | MED |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.4 | -42.4 |
| Trailing P/E | 5.8 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | -0.3% |
| Gross Margin | 0.2% | 0.7% |
| Operating Margin | 0.1% | -0.1% |
| EPS | 0.83 | -2.34 |
| Dividend Yield | 0.02% | — |